ModiQuest B.V. is one of the leading custom antibody generation and development providers
Business Model:
Revenue: $5M
Employees: 0-0
ModiQuest B.V. was acquired by
ImmunoPrecise Antibodies.
The acquisition happend on 2018-04-06.
Details of the transaction were not public
Address: Industrielaan 63
City: Oss
State: noord-holland
Zip: 5349
Country: NL
ModiQuest specializes in the generation of monoclonal antibodies against difficult target antigens for R&a;D, diagnostic and therapeutic applications. Using its proprietary ModiFuse™ (hybridoma electrofusion), ModiSelect™ (B-cell selection) and ModiPhage™ (phage display) technologies, ModiQuest can generate very large panels of monoclonal antibodies from various backgrounds such as mouse, rat, rabbit, chicken, llama and human, as well as transgenic animals harboring the human immunoglobulin (antibody) gene repertoire, against virtually any target. Besides antibody lead generation, ModiQuest also provides extensive antibody development and optimization procedures, such as affinity maturation, humanization, stable cell line generation and antibody production in transient and stable mammalian cell systems.
Contact Phone:
Contact Email:
Name | Price |
---|
Name | Size | Announced Date |
---|